Table 2.
Description of physician follow-up for youth in mild, moderate and severe PHQ-9 range.
| Follow up items | Mild N=149 |
Moderate N=132 |
Severe N=22 |
p value |
|---|---|---|---|---|
| Discussed lifestyle changes | 45 (30.2%) | 36 (27.3%) | 1 (4.5%) | 0.03 |
| Provided crisis line contact | 14 (9.4%) | 9 (6.8%) | 4 (18.2%) | 0.20 |
| In treatment/not interested | 19 (12.8%) | 8 (6.1%) | 4 (18.2%) | 0.06 |
| Reviewed support handout | 16 (10.7%) | 24 (18.2%) | 4 (18.2%) | 0.16 |
| Referred to psychotherapy | 51 (34.2%) | 61 (46.2%) | 16 (72.2%) | <0.01 |
| Not depressed | 34 (22.8%) | 26 (19.7%) | 0 (0.0%) | 0.02 |
| SSRI prescribing/considerationsa | ||||
| Started on SSRI | 11 (8.3%) | 7 (31.8%) | <0.01 | |
| Already on SSRI | 7 (4.7%) | 14 (10.6%) | 5 (22.7%) | 0.01 |
| Not depressed | 7 (4.7%) | 35 (26.5%) | 2 (9.1%) | <0.01 |
| Monitor SSRI every 2 wks | 16 (12.1%) | 4 (18.2%) | <0.01 | |
| Ordered TSH | 3 (2.0%) | 17 (12.9%) | 3 (13.6%) | <0.01 |
| Ordered free T4 | 17 (12.9%) | 3 (13.6%) | <0.01 | |
| Ordered CBC/UPT | 5 (3.4%) | 19 (14.4%) | 4 (18.2%) | <0.01 |
a
SSRI recommendations only provided for youth in moderate and severe ranges.